Scrip Asks...What Does 2019 Hold For Biopharma Part 3 Pricing Reimbursement And Market Access

Scrip Asks...What Does 2019 Hold For Biopharma? Part 3: Pricing, Reimbursement And Market Access

09:18 EST 15 Jan 2019 | SCRIP

How much therapies should cost and how they should be reimbursed are questions that are expected to dominate in 2019...